Campus - Financial Analyst - Full Time at Eli Lilly and Company

Indianapolis, Indiana, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Entry Level & New GradExperience Level
Full TimeJob Type
UnknownVisa
Healthcare, PharmaceuticalsIndustries

Requirements

  • Actively pursuing one of the following BA degrees: Business-related undergraduate degree with concentration/emphasis in Accounting, Finance, or Economics
  • Will graduate by August 2023
  • Language fluency in English (written and verbal)
  • Qualified candidates must be legally authorized to be employed in the United States (Lilly does not anticipate providing sponsorship for employment visa status, e.g., H-1B or TN status)

Responsibilities

  • Participate in the two-year Lilly Initial Financial Experience (LIFE) training program, providing an introduction to the broad spectrum of career paths at Lilly
  • Strengthen financial skills through a variety of financial assignments
  • Deepen financial expertise and learn/contribute to the business
  • Impact patients through work in finance
  • Engage in mentorship program, networking events, and career development opportunities

Questions & Answers

Common questions about this position

What is the salary for this Financial Analyst position?

This information is not specified in the job description.

Is this Financial Analyst role remote or office-based?

This information is not specified in the job description.

What are the basic qualifications for this role?

Candidates must be actively pursuing a business-related undergraduate degree with a concentration in Accounting, Finance, or Economics, graduating by August 2023, fluent in English, and legally authorized to work in the United States without sponsorship.

What is the company culture like at Eli Lilly?

Lilly offers a diverse culture committed to uniting individuals across cultures, a balance of work and life, opportunities for growth, and a vibrant community in downtown Indianapolis, while valuing integrity, excellence, respect for people, and making a difference in lives.

What makes a strong candidate for this Financial Analyst position?

Strong candidates are highly motivated leaders with integrity, excellence, and respect for people, pursuing a relevant business degree and graduating by August 2023, ready to join the Lilly Initial Financial Experience (LIFE) program for professional development.

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI